CANSoR
CANSoR offers a more accurate way to screen for prostate cancer with a quick, point-of-care test. It uses cell-free DNA analysis and AI to achieve high sensitivity and specificity for cancer detection. The company operates in the B2B healthcare diagnostics space, targeting clinicians and laboratories with a diagnostics workflow. This approach aims to reduce misdiagnosis, cut healthcare costs, and lessen the need for invasive screening methods. The plan is to scale across healthcare systems and expand cancer detection beyond prostate cancer.
CANSoR
CANSoR offers a more accurate way to screen for prostate cancer with a quick, point-of-care test. It uses cell-free DNA analysis and AI to achieve high sensitivity and specificity for cancer detection. The company operates in the B2B healthcare diagnostics space, targeting clinicians and laboratories with a diagnostics workflow. This approach aims to reduce misdiagnosis, cut healthcare costs, and lessen the need for invasive screening methods. The plan is to scale across healthcare systems and expand cancer detection beyond prostate cancer.